Full info forBOEHRINGER
| Application ID | 1-1967-32024 |
| Status | IE Pass |
| Prioritization Number | 1276 |
| TLD (#13) | BOEHRINGER |
| IDN Translation (#14b) | -- |
| Applicant (#1) | Boehringer Ingelheim Pharma GmbH & Co. KG |
| Website (#5) | http://www.boehringer-ingelheim.com |
| Application Type | |
| Type | Standard |
| Contested | no |
| Contested Numbers | 1 |
| GAC Early Warning | no |
| Cultural, Linguistic or Religious | no |
| dotBrand | yes |
| Trademark Class A | class 5 (pharma, dietetic food) |
| Trademark Class B | |
| Trademark Class C | |
| Industry Keyword | healthcare |
| Remark | Boehringer Ingelheim is a research-driven group of companies dedicated to researching and developing, manufacturing, and marketing pharmaceuticals that improve health and quality of life |
| Availability Data | |
| Sunrise Period: | fromunknown tounknown |
| Landrush Period: | fromunknown tounknown |
| GoLive: | unknown |
| Registration Policy | |
| Restricted | yes |
| Restrictions | dotbrand |
| Backend Provider | Afilias |
| Registry Website | |
| Keyword | |
| Keyword | no |
| English Meaning | -- |
| Appeal Ranking | 0 |
| Appeal Remark | Reserved for company and affiliate use only. |
| English | not applicable |
| Spanish | not applicable |
| Portuguese | not applicable |
| French | not applicable |
| Italian | not applicable |
| German | not applicable |
| Dutch | not applicable |
| Swedish | not applicable |
| Danish | not applicable |
| Mandarin | not applicable |
| Russian | not applicable |
| Location | |
| Region | Europe |
| Country | Germany |
| Community (#19) | -- |
| Geographic (#21a) | -- |
| Geographic Category | -- |
| IDN | |
| IDN (#14) | No |
| A-label (#14a) | -- |
| Translation (#14b) | -- |
| Script Code (#14d) | -- |
| Allows ASCII | yes |
| Applicant | |
| Applicant (#1) | Boehringer Ingelheim Pharma GmbH & Co. KG |
| Website (#5) | http://www.boehringer-ingelheim.com |
| Applicant Address (#2) | Binger Strasse 173 Ingelheim am Rhein Rhineland-Palatinate 55216 Germany [DE] |
| Applicant Phone (#3) | +496132772316 |
| Applicant Fax (#4) | +496132774566 |
| Legal Form (#8) | Corporation |
| Exchange Symbol (#9a) | |
| Parent Company (#9b) | B. C.H. Boehringer Sohn |
| Joint Venture Partners (#9c) | |
| Primary Contact | |
| Name (#6) | Gretchen Olive |
| Title (#6) | Director of Policy & Industry Affairs |
| e-mail (#6) | boehnewgtlds@cscinfo.com |
| Secondary Contact | |
| Name (#7) | Juergen Roemhild |
| Title (#7) | Head of CDept Intellectual Property Right and Unfair Competition (attorney) |
| e-mail (#7) | juergen.roemhild@boehringer-ingelheim.com |
| Mission / Purpose (#18a) | |
| CONFIDENTIAL Mission & Purpose (Question 18) – Boehringer Ingelheim 18.1.1 Boehringer Ingelheim Boehringer Ingelheim is a research-driven group of companies dedicated to researching and developing, manufacturing, and marketing pharmaceuticals that improve health and quality of life. Its businesses are Human Pharmaceuticals, Animal Health, Biopharmaceuticals and Chemicals. It focuses on innovative drugs and treatments that represent major therapeutic advances. Excellence in innovation and technology guides its actions in all areas. The company’s products have long been highly successful in the treatment of respiratory, cardiovascular, central nervous system, urological and infectious disorders. In addition, the company has successfully advanced its research in, amongst others, thromboembolic, cardio-metabolic, and oncological diseases. Boehringer Ingelheim has more than 42,000 employees in 145 affiliated companies, and operates global networks of research and development (R&D) facilities at seven sites and 20 production sites in 13 countries. Corporate headquarters are in Ingelheim, the same German town where the family-owned company was founded in 1885. The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped the company build on its strengths and make the most of its distinctive character. In a competitive and fast-changing world, the value of products, services and companies is constantly changing. Today, real customer value can only be created by constantly developing new solutions and by building upon Boehringer Ingelheim’s core principles. . 18.1.2 Describe the mission⁄purpose of your proposed gTLD The intended mission and purpose of the .boehringer gTLD is to serve as a trusted namespace for the benefit of Boehringer Ingelheim, its affiliated companies, Boehringer Ingelheim’s customers, the healthcare community and other Internet users. Although ICANN has not specifically recognized a .BRAND gTLD specification in the current gTLD application round, it is widely anticipated in the brand-owner community that this will become a specialty subset of gTLDs. .boehringer is intended to become one of those .BRAND gTLDs, with the goal of protecting and enhancing Boehringer Ingelheim’s online presence and identity, expanding its marketing and promotion efforts, and potentially providing a secure channel for its products and services, among other uses. Boehringer Ingelheim intends to initially use the .boehringer gTLD exclusively for corporate use. After the first few years of operation, and after analyzing the effect of new gTLDs on consumer behavior in the digital realm, Boehringer Ingelheim may evaluate whether opportunities exist to carry out the business strategy for the gTLD through expansion that continues the sustainable operations of the registry through registrations to parties other than Boehringer Ingelheim, such as licensees, alliance partners or customers. Boehringer Ingelheim will operate the .boehringer gTLD in ways that are consistent with the business strategies of these or its other business segments as identified in its annual report and investor filings, see: http:⁄⁄www.boehringer-ingelheim.com⁄corporate_profile⁄annual_report.html. |
|
If you wish to download the application information pertaining to this new gTLD, please select your download preference below: 1) A PDF compilation of the information provided by eBrand Services will be generated for you.; 2) The public portion of the application made available by ICANN will be generated.
Be informed about the status of applicationBOEHRINGER
Do you want to be kept up to date with the application status for a domain under a new gTLD?
We understand that the roll out of the new gTLD’s is a long process and you may be undecided on the specific domain you wish to pursue. Nonetheless, if you would like to be informed about the progress of a particular new gTLD, and all essential elements (policies, pricing, launch schedules, and registration deadlines), request a follow up and join our watchlist. Alternatively, let us review your business/situation and supply you with a customized solution fitting your individual needs.
File an objection for applicationBOEHRINGER
eBrand Services has designed a series of defensive approaches to ensure that rightholders can object applications of new gTLD that affect their interests asserting prior rights over certain string or Trademark. Contact us to know more:
Express your interest for a domain name under the extensionBOEHRINGER
An Expression of Interest allows you to submit a non-binding interest in registering the specific domains most relevant to you. By doing so, we can provide you with up-to-date information about launch schedules, pricing, policies, and ensure you avoid missing registration deadlines. Prior to the release of your domain name under a new gTLD, we will let you know and we can assist you in turning your Expression of Interest into a binding registration order, or cancel your Expression of Interest. Whilst we will endeavor to secure your desired domain for you, please note that we cannot guarantee a successful registration. It is important to acknowledge that multiple registration phases will take place. For more information, please refer our FAQ’s. All Expression of Interest’s are free of charge and legally non-binding.
Additionally, let us review your business/situation and supply you with a customized solution fitting your individual needs.
Contact us to know more: